37.94
-0.38(-0.99%)
Currency In USD
| Previous Close | 38.32 |
| Open | 38.33 |
| Day High | 39.01 |
| Day Low | 37.13 |
| 52-Week High | 42.29 |
| 52-Week Low | 23.23 |
| Volume | 269,634 |
| Average Volume | 355,617 |
| Market Cap | 1.2B |
| PE | 35.79 |
| EPS | 1.06 |
| Moving Average 50 Days | 34.04 |
| Moving Average 200 Days | 30.73 |
| Change | -0.38 |
If you invested $1000 in Collegium Pharmaceutical, Inc. (COLL) 10 years ago, it would be worth $2,560.05 as of September 08, 2025 at a share price of $37.94. Whereas If you bought $1000 worth of Collegium Pharmaceutical, Inc. (COLL) shares 5 years ago, it would be worth $2,060.84 as of September 08, 2025 at a share price of $37.94.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Collegium to Report Second Quarter 2025 Financial Results on August 7, 2025
GlobeNewswire Inc.
Jul 24, 2025 12:00 PM GMT
STOUGHTON, Mass., July 24, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that it will report second quarter 2025 financial results before the market opens on Thursday, August 7, 2025. Following the release o
Collegium Announces $150 Million Share Repurchase Program
GlobeNewswire Inc.
Jul 07, 2025 12:00 PM GMT
STOUGHTON, Mass., July 07, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced i
Collegium Announces $25 Million Accelerated Share Repurchase Program
GlobeNewswire Inc.
May 12, 2025 12:05 PM GMT
STOUGHTON, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced th